Improving patient outcomes and addressing unmet medical needs through development and delivery of high-quality pharmaceutical products.
We believe in innovative approaches in evaluating and repurposing approved drugs to meet patient’s unmet needs.
We leverage our formulation and clinical development expertise to develop unique value-added solutions to help patients.
Our Portfolio
Discover our diverse portfolio, offering both 505(B)(2) and 505(J) products, skillfully balancing the risk. Our value proposition is rooted in an innovative and dynamic healthcare approach, emphasizing the repurposing of existing drugs and development of complex generics
About Us
6S Pharma (6S) is pioneering a unique approach to advancing the field of medicine, the startup is focused on the development of innovative healthcare solutions that address unmet patient needs. With multiple 505 (B)(2) products in the pipeline at various stages along with expanded and diversified focus on complex generic products, this early-stage start-up preparing to file IND applications for two products in their portfolio and proceed to human P.O.C. studies.
The value proposition and innovation at 6S Pharma revolve around its dedication to transforming healthcare through unique approaches and solutions. Here are key aspects of 6S Pharma's value proposition and innovation
Innovative Approaches
We excel in repurposing approved drugs, showcasing a creative and adaptive approach.
Dynamic and Value-Centric Portfolio
The proficiency in repurposing approved drugs contributes to the creation of a dynamic and value-centric portfolio.
Strategic Expansion into Complex Generics
6S strategically has expanded its focus by venturing into complex generic drugs.
Targeting Diverse Indications
Each product within this portfolio addresses substantial market needs exceeding $2 billion, demonstrating a strategic alignment with high-demand areas in healthcare.
Global Marketing Strategies
6S Pharma integrates its unique and diverse portfolio with global marketing strategies.
Out-Licensing Success and Future Growth
The successful out-licensing of one of the complex generic formulations showcases business acumen and collaboration.